Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 09
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
296
+0.68%
|
-
|
Jun 09
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
307
+1.14%
|
-
|
Jun 09
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
296
+1.51%
|
-
|
Jun 09
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+0.41%
|
-
|
Jun 09
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+0.92%
|
-
|
Jun 09
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
254
+1.45%
|
-
|
Jun 09
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
254
+10.39%
|
-
|
May 29
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-10.97%
|
$3,450,000
$115.47 P/Share
|
May 29
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.89%
|
$2,340,000
$78.66 P/Share
|
May 28
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
20,217
-73.38%
|
$2,345,172
$116.12 P/Share
|
May 28
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,217
+42.32%
|
$1,576,926
$78.66 P/Share
|
May 28
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
130,626
-49.98%
|
$15,152,616
$116.37 P/Share
|
May 28
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
130,626
+33.32%
|
$10,188,828
$78.66 P/Share
|
May 27
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Discretionary transaction
|
Indirect |
1,242
-40.76%
|
$140,346
$113.13 P/Share
|
May 15
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
404,714
-1.81%
|
$45,732,682
$113.47 P/Share
|
May 14
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
7,164,819
-13.16%
|
$802,459,728
$112.69 P/Share
|
May 13
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
1,005,263
-2.6%
|
$114,599,982
$114.73 P/Share
|
Apr 24
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
3,500,000
-15.29%
|
$416,500,000
$119.21 P/Share
|
Apr 23
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
4,000,000
-14.87%
|
$476,000,000
$119.21 P/Share
|
Apr 22
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
2,033,735
-7.03%
|
$244,048,200
$120.0 P/Share
|
Apr 21
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
25,600
-50.59%
|
$3,046,400
$119.5 P/Share
|
Apr 21
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Exercise of conversion of derivative security
|
Direct |
25,600
+33.6%
|
$1,612,800
$63.05 P/Share
|
Apr 21
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
7,360
-14.13%
|
$883,200
$120.0 P/Share
|
Apr 21
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
287,202
-0.98%
|
$34,177,038
$119.65 P/Share
|
Apr 20
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
1,813,227
-1.98%
|
$221,213,694
$122.12 P/Share
|
Apr 20
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
12,589
-21.88%
|
$1,535,858
$122.68 P/Share
|
Mar 10
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+0.98%
|
-
|
Mar 10
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+0.58%
|
-
|
Mar 10
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+1.3%
|
-
|
Mar 10
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
208
+1.21%
|
-
|
Mar 10
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+11.46%
|
-
|
Mar 10
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
291
+0.36%
|
-
|
Mar 10
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
312
+0.92%
|
-
|
Feb 28
2020
|
Steven D Bishop CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
3,697
+8.27%
|
-
|
Feb 28
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
6,241
+9.79%
|
-
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
604
+7.64%
|
-
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,728
+5.59%
|
-
|
Feb 28
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
3,622
+5.97%
|
-
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
2,509
+18.59%
|
-
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
11,255
+17.76%
|
-
|
Feb 28
2020
|
David S Taylor Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
30,359
+11.12%
|
-
|
Feb 28
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Grant, award, or other acquisition
|
Direct |
14,785
+13.53%
|
-
|
Feb 28
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
14,061
-6.21%
|
$1,546,710
$110.44 P/Share
|
Feb 28
2020
|
Peltz Nelson Director |
SELL
Other acquisition or disposition
|
Indirect |
113,753
-0.37%
|
$12,854,089
$113.23 P/Share
|
Feb 28
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
1,641
-2.98%
|
$180,510
$110.44 P/Share
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
1,041
-10.94%
|
$114,510
$110.44 P/Share
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
4,311
-9.55%
|
$474,210
$110.44 P/Share
|
Feb 28
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
2,275
-2.77%
|
$250,250
$110.44 P/Share
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
387
-5.46%
|
$42,570
$110.44 P/Share
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
3,185
-2.53%
|
$350,350
$110.44 P/Share
|